U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 0) by Anonymous Coward on Wednesday January 23 2019, @11:39PM (1 child)
Not a good analogy. It isn't inevitable that someone is going to break the lock. It is inevitable that politicians will mess up whatever it is they try to do and make it 10x more expensive than it needs to be (at least in the US).
(Score: 2) by hendrikboom on Friday January 25 2019, @02:54PM
What is it about the US that ensures that politicians will mess up whatever it is they try to do and make it 10x more expensive than it needs to be?
Is it something in the constitution that has this effect?
-- hendrik